Our recent study showed that NSC-CM increased depigmentation via the inhibition of Wnt/β-catenin signaling pathway by triggering DKK1 upregulation in a melanoma cell line and subsequent downregulation of the expression of MITF and melanogenic enzymes [30,90]. This evidence concerns the gene DKK1 and melanoma.